Clinical Trial Update: RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating different nucleoside analogue regimens on prognosis after curative resection in HBV-related hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbv Coinfection
• Hepatocellular Carcinoma

Snippet

Sponsor: West China Hospital | Conditions: HCC, HBV Coinfection | Phase 4 | Status: ACTIVE_NOT_RECRUITING